Form 4: Absci CFO/CBO Receives Significant Equity Awards

Absci Corp's CFO/CBO, Zachariah Jonasson, reported the acquisition of restricted stock units and stock options, alongside a tax-related share disposition.

Summary

• Zachariah Jonasson, CFO/CBO of Absci Corp, reported the acquisition of 135,400 shares of Common Stock in the form of Restricted Stock Units (RSUs) on March 2, 2026, with a price of $0.
• These RSUs are part of the Absci Corporation 2021 Stock Option and Incentive Plan and will vest in three substantially equal annual installments, beginning March 1, 2027, contingent on continuous service.
• On March 3, 2026, Jonasson disposed of 10,848 shares of Common Stock at a price of $2.8 per share; this transaction covered tax withholding obligations related to RSU vesting and was not a discretionary trade.
• Jonasson also acquired 534,400 stock options (right to buy) on March 2, 2026, with an exercise price of $2.8 per share.
• These stock options will vest over a three-year period in substantially equal annual installments, with the first installment vesting on March 1, 2027, subject to continuous service, and expire on February 29, 2036.
• Following these transactions, Jonasson beneficially owns 499,783 shares of Common Stock and 534,400 derivative securities (stock options).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive alignment and retention through long-term equity incentives, which is generally favorable for corporate governance and shareholder value.

Positives

• The grant of 135,400 Restricted Stock Units and 534,400 stock options to a key executive like the CFO/CBO aligns management's long-term interests with those of shareholders.
• The equity awards are tied to continuous service, providing an incentive for executive retention and commitment to Absci Corp's future performance.

Future Outlook

The Restricted Stock Units and stock options granted to the CFO/CBO are subject to a three-year vesting schedule, with the first installment vesting on March 1, 2027, contingent on continuous service. The stock options have an expiration date of February 29, 2036.

Industry Context

StockSavvy.ai notes that the grant of equity awards, such as RSUs and stock options, is a standard practice in the biotechnology and technology sectors for executive compensation. This approach aims to align the interests of key management personnel with long-term shareholder value creation and to incentivize executive retention in a competitive talent market.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants align the CFO/CBO's financial interests with long-term shareholder value, potentially leading to more focused strategic decisions aimed at increasing stock price.
• Employees: The compensation structure for a key executive may set a precedent or reflect the company's overall approach to incentivizing its leadership team.

Next Steps

• Continued service of the Reporting Person to the Issuer for the RSUs and stock options to vest according to the established schedule.
• Future vesting events for RSUs and stock options on March 1, 2027, and subsequent annual installments.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation in the form of RSU and stock option grants, along with a non-discretionary tax-related share disposition. While the grants are a positive for executive alignment and retention, they do not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, suggesting investors maintain their current position based on this informational update.

Keywords

Absci Corp, ABSI, Zachariah Jonasson, CFO, CBO, Restricted Stock Units, RSUs, Stock Options, Equity Awards, Insider Transaction, Executive Compensation, SEC Form 4